NYSE - Delayed Quote USD

Edison International (EIX)

Compare
85.43 +0.79 (+0.93%)
At close: October 18 at 4:00 PM EDT
85.43 0.00 (0.00%)
After hours: October 18 at 5:29 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 4.34B
Earnings 439M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

72.00 Low
89.35 Average
85.43 Current
100.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1091516
Avg. Estimate 1.411.184.945.61
Low Estimate 1.331.114.825.31
High Estimate 1.571.245.055.76
Year Ago EPS 1.381.284.764.94

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 551414
Avg. Estimate 5.01B3.9B17.45B18.26B
Low Estimate 4.77B3.79B16.57B17.35B
High Estimate 5.4B4.03B19.09B19.88B
Year Ago Sales --3.71B16.34B17.45B
Sales Growth (year/est) --5.10%6.80%4.60%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. 1.461.161.141.07
EPS Actual 1.381.281.131.23
Difference -0.080.12-0.010.16
Surprise % -5.50%10.30%-0.90%15.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 1.411.184.945.61
7 Days Ago 1.431.174.955.61
30 Days Ago 1.441.174.955.6
60 Days Ago 1.431.154.935.61
90 Days Ago 1.491.274.975.64

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --1----
Up Last 30 Days --1--1
Down Last 7 Days --------
Down Last 30 Days 1--11

Growth Estimates

CURRENCY IN USD EIXIndustrySectorS&P 500
Current Qtr. 2.20%----3.70%
Next Qtr. -7.80%----7.90%
Current Year 3.80%----2.50%
Next Year 13.60%----13.10%
Next 5 Years (per annum) 8.15%----11.88%
Past 5 Years (per annum) 0.89%------

Upgrades & Downgrades

Maintains Barclays: Equal-Weight to Equal-Weight 10/15/2024
Maintains RBC Capital: Outperform to Outperform 10/4/2024
Maintains Morgan Stanley: Underweight to Underweight 9/25/2024
Reiterates RBC Capital: Outperform to Outperform 9/16/2024
Maintains Argus Research: Buy to Buy 9/11/2024
Maintains UBS: Neutral to Neutral 9/4/2024

Related Tickers